Nominal Benefits Seen in Drugs for Alzheimer's

Nominal Benefits Seen in Drugs for Alzheimer's - Denise...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
Denise Grady 11/16/2005 Nominal Benefits Seen in Drugs for Alzheimer's The drugs now available to treat the memory and thinking problems of Alzheimer's disease have not lived up to the public's high expectations for them and offer such modest benefits on average that many doctors are unsure about whether to prescribe them. Although the drugs have their advocates, grateful for any sign of improvement, others express disappointment in light of earlier hopes that the drugs approved in the last decade would stop the disease or markedly slow it. At a meeting in late March at Johns Hopkins University, doctors and other health professionals heard Alzheimer's researchers debate the usefulness of the drugs and the prospects of better treatments becoming available any time soon. Some researchers say it may be decades before real progress is made in reducing the toll of the disease. When a frustrated doctor in the audience accused a panel of experts of evading the question of whether the drugs should be prescribed, the auditorium burst into applause. One expert replied that there was just one chance in 10 that the drugs would have an
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

Page1 / 2

Nominal Benefits Seen in Drugs for Alzheimer's - Denise...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online